Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...